The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in ...

A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...

Health care providers are urged to inform patients to periodically check their smartphone settings and to confirm that they are able to receive alerts.

Approval of this indication is based on limited clinical safety and efficacy data for Emblaveo. In REVISIT, study participants with cIAI (n=312) were randomly assigned 2:1 to receive aztreonam ...

HealthDay News — A new strain of bird flu, H5N9, has been detected for the first time in the US, raising concerns about how it continues to spread. The strain was discovered at a commercial duck farm ...

Credit: Supernus Qelbree is a selective norepinephrine reuptake inhibitor. The transfer of the drug into breastmilk was reported to be low. The prescribing information for Qelbree ® (viloxazine ...

Ozempic (semaglutide) Glucagon-like peptide-1 receptor agonist To reduce the risk of sustained estimated glomerular filtration rate decline, end-stage kidney disease, and cardiovascular death in ...

The researchers found that 69,213,936 prescriptions for OMDs were dispensed in the United States during the study period, (HealthDay News) — Prescriptions of obesity management drugs (OMDs) have ...

A higher risk for ischemic heart diseases was associated with IBD only in male patients, whereas a negative association was seen among female patients. HealthDay News — Male patients with ...